PALI
PALI
NASDAQ · Biotechnology

Palisade Bio Inc

$1.64
+0.14 (+9.33%)
As of Feb 8, 2:02 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 116.39M 123.33M 94.21M
Net Income 12.19M 12.43M 9.10M
EPS
Profit Margin 10.5% 10.1% 9.7%
Rev Growth -3.2% +20.3% +7.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 104.47M 93.65M 105.99M
Total Equity 176.98M 160.18M 164.42M
D/E Ratio 0.59 0.58 0.64
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 16.58M 20.40M 14.08M
Free Cash Flow 11.50M 12.12M 8.26M